(Q43175236)

English

Targeted therapy for biliary-tract cancer

scientific article published in January 2010

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20129124

retrieved

15 November 2017

title

Targeted therapy for biliary-tract cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15 November 2017

Junji Furuse

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20129124

retrieved

15 November 2017

publication date

1 January 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20129124

retrieved

15 November 2017

published in

Lancet Oncology Commission

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20129124

retrieved

15 November 2017

volume

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20129124

retrieved

15 November 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20129124

retrieved

15 November 2017

page(s)

5-6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20129124

retrieved

15 November 2017

cites work

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970370-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970370-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970370-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970370-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970370-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S1470-2045(09)70370-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20129124

retrieved

15 November 2017

PubMed publication ID

20129124

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20129124

retrieved

15 November 2017

ResearchGate publication ID

41404093

0 references

(Q43175236)

Targeted therapy for biliary-tract cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)